ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

Screening Guidelines: When Scientists Can’t Agree, What’s The Press To Do?

May 15, 1998

NCAB Discussion Of Working Group Report

February 28, 2003

In Brief: Senate Subcommittee Adds $100 Million For NCI Over House Bill, No Further Action Until Sept.

August 8, 1975

Digital Microscope Blood Test Identifies Circulating Tumor Cells

February 24, 2012

Seffrin, Thomas Lead List of ACS Exec. VP Candidates, Reportedly

May 1, 1992

In Brief: James Institute Receives $9 Million Gift; NCI’s Fraumeni Wins Public Health Award

November 3, 1995